Eltayeb v. Akron Nephrology Assoc.

2025 Ohio 248
CourtOhio Court of Appeals
DecidedJanuary 29, 2025
Docket30992
StatusPublished

This text of 2025 Ohio 248 (Eltayeb v. Akron Nephrology Assoc.) is published on Counsel Stack Legal Research, covering Ohio Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Eltayeb v. Akron Nephrology Assoc., 2025 Ohio 248 (Ohio Ct. App. 2025).

Opinion

[Cite as Eltayeb v. Akron Nephrology Assoc., 2025-Ohio-248.]

STATE OF OHIO ) IN THE COURT OF APPEALS )ss: NINTH JUDICIAL DISTRICT COUNTY OF SUMMIT )

BABIKER ELTAYEB, M.D. C.A. No. 30992

Appellee

v. APPEAL FROM JUDGMENT ENTERED IN THE AKRON NEPHROLOGY ASSOCIATES, COURT OF COMMON PLEAS INC. COUNTY OF SUMMIT, OHIO CASE No. CV-2017-06-2590 Appellant

DECISION AND JOURNAL ENTRY

Dated: January 29, 2025

HENSAL, Judge.

{¶1} Akron Nephrology Associates, Inc. (“ANA”) appeals a judgment of the Summit

County Court of Common Pleas that awarded $451,607.00 to Babiker Eltayeb, M.D. and an order

that denied its motion for remittitur, denied its motion for new trial, and granted Dr. Eltayeb

attorney fees. For the following reasons, this Court affirms.

I.

{¶2} Dr. Eltayeb began working for ANA in 1998 and eventually became a shareholder

in the company. In March 2017, Dr. Eltayeb let his partners know that he was retiring from the

practice. He, thereafter, sought a buyout of his shares under the terms of the shareholders

agreement. ANA opposed the buyout because it did not believe Dr. Eltayeb had retired because

he went to work in another country. Dr. Eltayeb sued ANA for breach of contract and two of his

partners for breach of fiduciary duty. A jury found ANA liable for breach of contract and awarded

Dr. Eltayeb $451,607 in damages. The trial court also awarded Dr. Eltayeb his attorney fees, in 2

accordance with the shareholders agreement, and prejudgment interest. ANA moved for remittitur

or, in the alternative, for a new trial of the damages, arguing that the jury’s award was not supported

by the evidence. The trial court, however, denied its motions. ANA has appealed, assigning four

errors.

II.

ASSIGNMENT OF ERROR I

THE TRIAL COURT ERRED WHEN IT DENIED AKRON NEPHROLOGY’S MOTION FOR REMITTITUR AND ALTERNATIVE REQUEST FOR NEW TRIAL WHERE THERE WAS NO COMPETENT, SUBSTANTIAL, AND CREDIBLE EVIDENCE TO SUPPORT THE JURY’S VERDICT OF $451,607.00 ON ELTAYEB’S BREACH OF CONTRACT CLAIM.

{¶3} In its first assignment of error, ANA argues that the trial court should have granted

its motion for remittitur or for new trial because the jury’s award is not supported by the evidence.

It notes that Dr. Eltayeb argued that the retirement buyout price was $702,994, while it argued that

the buyout price was $306,830.18. The jury awarded $451,607, however, which ANA argues is

not supported by the evidence.

{¶4} Regarding ANA’s motion for remittitur, “courts have the inherent authority to order

remittiturs to reduce jury awards when they deem the amount to be excessive based on facts found

by the jury.” Arbino v. Johnson & Johnson, 2007-Ohio-6948, ¶ 38. “This Court reviews a trial

court’s decision to deny remittitur for an abuse of discretion.” Jemson v. Falls Village Retirement

Community, Ltd., 2002-Ohio-4155, ¶ 26 (9th Dist.).

{¶5} Regarding ANA’s motion for new trial, Civil Rule 59(A) provides that a new trial

may be granted on the grounds of an “[e]rror in the amount of recovery, whether too large or too

small” or if “[t]he judgment is not sustained by the weight of the evidence . . . .” Civ.R. 59(A)(5)

& (6). If the basis of a motion for new trial “involves a question of law, the de novo standard of 3

review applies, and when the basis of the motion involves the determination of an issue left to the

trial court’s discretion, the abuse of discretion standard applies.” Dragway 42, L.L.C. v. Kokosing

Constr. Co., Inc., 2010-Ohio-4657, ¶ 32 (9th Dist.).

When considering a Civ.R. 59(A)(6) motion for a new trial, a trial court must weigh the evidence and pass on the credibility of the witnesses. Yet, the trial court assesses the weight and credibility in a more limited sense than would a jury; the court is to determine, in light of its broad discretion, whether a manifest injustice has occurred.

DiDonato v. Roig, 2024-Ohio-2109, ¶ 18 (9th Dist.), quoting Windward Ents., Inc. v. Valley City

Dev. Group LLC, 2019-Ohio-3419, ¶ 18 (9th Dist.).

{¶6} “A claimant seeking to recover for breach of contract must show damage as a result

of the breach.” Textron Fin. Corp. v. Nationwide Mut. Ins. Co., 115 Ohio App.3d 137, 144 (9th

Dist. 1996). “Damages are not awarded for a mere breach of contract; the amount of damages

awarded must correspond to injuries resulting from the breach.” Id. “As a general rule, an injured

party cannot recover damages for breach of contract beyond the amount that is established by the

evidence with reasonable certainty, and generally, courts have required greater certainty in the

proof of damages for breach of contract than in tort.” Id., quoting Rhodes v. Rhodes Indus., Inc.,

71 Ohio App.3d 797, 808-809 (8th Dist. 1991). “The damages awarded for a breach of contract

should place the injured party in as good a position as it would have been in but for the breach.”

Id. “Such compensatory damages, often termed ‘expectation damages,’ are limited to actual loss,

which loss must be established with reasonable certainty.” Id.

{¶7} The shareholders agreement provided that the purchase price for the shares of a

retiring shareholder would be “equal to the average annual compensation of full time Shareholders

during the prior three (3) full calendar years . . . from the date of the [retirement] notice . . . [.]”

The parties disagreed over the meaning of the term “compensation.” According to Dr. Eltayeb, 4

ANA had two sources of income. First, each of the doctors had a clinical practice consulting with

patients at their office or a hospital. Second, the owner of multiple dialysis centers had hired ANA

to provide physician services at its centers. Dr. Eltayeb testified that his compensation from ANA

consisted of both his income from clinical visits and his share of the income from the dialysis

centers. ANA, however, argued that a shareholder’s “compensation” only included a doctor’s

clinical fees.

{¶8} ANA had three shareholders at the time of Dr. Eltayeb’s retirement. Dr. Eltayeb

averaged the amount he claimed they each received in clinical and dialysis-center fees in 2014,

2015, and 2016, to reach his buyout-entitlement figure of $702,944. ANA, on the other hand, only

averaged the shareholders’ clinical fees from 2014, 2015, and 2016, to calculate its buyout figure

of $306,830.18

{¶9} Based on the evidence submitted, we conclude the jury award of $451,607 cannot

be deemed excessive because it was less than Dr. Eltayeb could reasonably argue he was entitled

to under the buyout provision of the shareholders agreement. Although there is no clear indication

for why the jury settled on $451,607, we also cannot say that the amount is not supported by the

weight of the evidence. Dr. Eltayeb presented evidence that would support a damage award up to

and including the full amount he requested. We also note that ANA presented a copy of Dr.

Eltayeb’s employment contract from his new employer. In determining how much Dr. Eltayeb

was injured by ANA’s breach of contract, the jury may have considered his injury to have been

mitigated by his compensation at his new employer, which Dr. Eltayeb testified was about

$200,000 a year. Upon review of the record, we conclude that ANA has failed to establish that

the trial court improperly exercised its discretion when it denied the motion for remittitur and

motion for new trial. ANA’s first assignment of error is overruled. 5

ASSIGNMENT OF ERROR II

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Arbino v. Johnson & Johnson
2007 Ohio 6948 (Ohio Supreme Court, 2007)
Moretz v. Muakkassa
2013 Ohio 4656 (Ohio Supreme Court, 2013)
Magnum Steel & Trading, L.L.C. v. Mink
2013 Ohio 2431 (Ohio Court of Appeals, 2013)
Rhodes v. Rhodes Industries, Inc.
595 N.E.2d 441 (Ohio Court of Appeals, 1991)
Cambridge Co., Ltd. v. Telsat, Inc., 23935 (3-12-2008)
2008 Ohio 1056 (Ohio Court of Appeals, 2008)
Textron Financial Corp. v. Nationwide Mutual Insurance
684 N.E.2d 1261 (Ohio Court of Appeals, 1996)
Burkett v. Cook, Unpublished Decision (9-12-2007)
2007 Ohio 4652 (Ohio Court of Appeals, 2007)
Hagemeyer v. Sadowski
621 N.E.2d 707 (Ohio Court of Appeals, 1993)
Weaner & Assos., L.L.C. v. 369 W. First St., L.L.C.
2016 Ohio 8077 (Ohio Court of Appeals, 2016)
Windward Ents., Inc. v. Valley City Dev. Group, L.L.C.
2019 Ohio 3419 (Ohio Court of Appeals, 2019)
Woodside Mgt. Co. v. Bruex
2020 Ohio 4039 (Ohio Court of Appeals, 2020)
Nottingdale Homeowners' Ass'n v. Darby
514 N.E.2d 702 (Ohio Supreme Court, 1987)
Bittner v. Tri-County Toyota, Inc.
569 N.E.2d 464 (Ohio Supreme Court, 1991)
Ziegler v. Wendel Poultry Services, Inc.
615 N.E.2d 1022 (Ohio Supreme Court, 1993)
Freeman v. Norfolk & Western Railway Co.
635 N.E.2d 310 (Ohio Supreme Court, 1994)
HB Martin Logistics, Inc. v. Hissong Group, Inc.
2023 Ohio 4836 (Ohio Court of Appeals, 2023)
Vitantonio v. Am. Constr. Group, L.L.C.
2024 Ohio 325 (Ohio Court of Appeals, 2024)
Loewe v. Loewe
2024 Ohio 323 (Ohio Court of Appeals, 2024)
DiDonato v. Roig
2024 Ohio 2109 (Ohio Court of Appeals, 2024)

Cite This Page — Counsel Stack

Bluebook (online)
2025 Ohio 248, Counsel Stack Legal Research, https://law.counselstack.com/opinion/eltayeb-v-akron-nephrology-assoc-ohioctapp-2025.